Elan's Nifelin
Executive Summary
Once-a-day nifedipine NDA was filed on July 31. In a recent annual report, the company said it had completed clinical trials with Nifelin in 400 patients in the U.S. Elan said results show that Nifelin maintains a "remarkably flat" blood pressure profile over a 24-hour period.